Transcriptional regulation by epigenetic factors

表观遗传因素的转录调控

基本信息

  • 批准号:
    7782402
  • 负责人:
  • 金额:
    $ 30.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-01 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In development, changes in gene expression patterns define cell identity. These specific gene expression patterns are established at early embryonic stages, and must be passed on to daughter cells after cell division, a process termed epigenetic maintenance. The underlying mechanisms are achieved by the highly conserved trithorax-group (trxG) and Polycomb-group (PcG) proteins, which are responsible for the maintenance of transcriptional activation and repression, respectively, of numerous target genes. The roles of these proteins in transcription remain obscure, and the way they pass epigenetic information during the cell cycle is completely unknown. We found that trxG proteins are essential for transcriptional elongation. We also found that during DNA replication several trxG and PcG proteins remain stably associated with their binding sites on DNA in vivo. The goal of this proposal is to test two hypotheses: (1) that establishment of epigenetic maintenance is achieved by the complex interactions between trxG and PcG proteins; and (2) once the status of gene expression is determined, these proteins serve as epigenetic marks during the cell cycle to pass this information to daughter cells. To test the first hypothesis, we developed a technique that allows biochemical analysis of the chromatin composition of the trxG-activated and the PcG-silenced Hox target gene Ultrabithorax at very early blastoderm stages of embryo development. During these stages epigenetic maintenance is being established. Using this technique, we propose to address the following questions: (i) What is the role of PcG proteins in transcriptional repression during the establishment and maintenance of epigenetic transcription status in vivo? (ii) What are the molecular differences between active and silenced Ubx during establishment and maintenance phases? (iii) Do the opposing groups of regulators act antagonistically or independently? To test our second hypothesis, we developed a new in vivo approach to examine association of chromosomal proteins and histones with specific chromatin domains during DNA replication. This approach will be used to (iv) test the hypothesis that trxG and PcG proteins are essential epigenetic marks in re-establishing chromatin domains of the target gene following DNA replication. Given conservation of the function of trxG and PcG proteins in higher eukaryotes, these studies will greatly advance our knowledge of the basic mechanisms of transcriptional regulation and epigenetic inheritance and their relevance to diseases like cancer. PUBLIC HEALTH RELEVANCE: The epigenetic program that determines the status of gene expression in a particular part of the body is established very early during embryo development, and any perturbations in this program may lead to death or diseases, like cancer. Once this program is established, the state of gene activity in each cell has to be faithfully inherited in daughter cells. The aim of this project is to understand the mechanisms that underline the regulatory events that are essential for the establishment, maintenance and inheritance of these epigenetic programs in embryogenesis.
描述(由申请人提供):在开发中,基因表达模式的变化定义了细胞身份。这些特定的基因表达模式是在早期胚胎阶段建立的,必须在细胞分裂后传递给子细胞,该过程称为表观遗传学维持。潜在的机制是通过高度保守的Trithorax-group(TRXG)和Polycomb-Group(PCG)蛋白来实现的,这些蛋白分别负责维持众多靶基因的转录激活和抑制。这些蛋白质在转录中的作用仍然晦涩难懂,并且它们在细胞周期中传递表观遗传信息的方式是完全未知的。我们发现TRXG蛋白对于转录伸长至关重要。我们还发现,在DNA复制过程中,几种TRXG和PCG蛋白与体内DNA上的结合位点保持稳定。该提案的目的是检验两个假设:(1)通过TRXG和PCG蛋白之间的复杂相互作用来实现表观遗传维持的建立; (2)一旦确定了基因表达的状态,这些蛋白质在细胞周期中充当表观遗传标记,将这些信息传递给子细胞。为了检验第一个假设,我们开发了一种技术,该技术允许对胚胎发育的早期胚胚阶段的TRXG激活和PCG中含有PCG的HOX靶基因的染色质组成。在这些阶段期间,正在建立表观遗传维护。使用此技术,我们建议解决以下问题:(i)PCG蛋白在体内表观遗传转录状态期间在转录抑制中的作用是什么? (ii)在建立和维护阶段,主动和沉默的UBX之间的分子差异是什么? (iii)对立的监管机构是在拮抗或独立的吗?为了检验我们的第二个假设,我们开发了一种新的体内方法,以检查DNA复制过程中染色体蛋白和组蛋白与特定染色质结构域的关联。这种方法将用于(iv)检验以下假设:在DNA复制后,TRXG和PCG蛋白是重新建立靶基因的染色质结构域的必不可少的表观遗传标记。鉴于较高真核生物中TRXG和PCG蛋白的功能的保存,这些研究将大大提高我们对转录调控和表观遗传遗传的基本机制的了解及其与癌症等疾病的相关性。 公共卫生相关性:确定基因表达在身体特定部分状态的表观遗传学计划在胚胎发育期间很早就建立,并且该计划中的任何扰动都可能导致死亡或疾病(如癌症)。一旦建立了该程序,就必须在子细胞中忠实地遗传每个细胞中的基因活性状态。该项目的目的是了解强调对这些表观遗传程序在胚胎发生中建立,维护和遗传至关重要的监管事件的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER M MAZO其他文献

ALEXANDER M MAZO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER M MAZO', 18)}}的其他基金

Structure of post-replicative chromatin during cell reprogramming in fibrotic disease
纤维化疾病细胞重编程过程中复制后染色质的结构
  • 批准号:
    9895805
  • 财政年份:
    2017
  • 资助金额:
    $ 30.9万
  • 项目类别:
The Role of Epigenetic Factors in Regulation of Coding and Non-Coding HOX Genes
表观遗传因素在编码和非编码 HOX 基因调控中的作用
  • 批准号:
    7617339
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
TRANSCRIPTIONAL REGULATION BY EPIGENETIC FACTORS
表观遗传因素的转录调控
  • 批准号:
    7476459
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
Transcriptional Regulation by Epigenetic Factors
表观遗传因素的转录调控
  • 批准号:
    9915931
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
TRANSCRIPTIONAL REGULATION BY EPIGENETIC FACTORS
表观遗传因素的转录调控
  • 批准号:
    7092638
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
Transcriptional regulation by epigenetic factors
表观遗传因素的转录调控
  • 批准号:
    8389592
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
Transcriptional regulation by epigenetic factors
表观遗传因素的转录调控
  • 批准号:
    8753785
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
Transcriptional regulation by epigenetic factors
表观遗传因素的转录调控
  • 批准号:
    9060950
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
TRANSCRIPTIONAL REGULATION BY EPIGENETIC FACTORS
表观遗传因素的转录调控
  • 批准号:
    6961404
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
Transcriptional regulation by epigenetic factors
表观遗传因素的转录调控
  • 批准号:
    8197620
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:

相似国自然基金

熏蒸结合动物堆肥对土壤-蔬菜系统抗生素抗性基因的影响机制
  • 批准号:
    42307033
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
  • 批准号:
    82201339
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
一种新型PRC1变体在不同细胞类型中的结合动态与功能研究
  • 批准号:
    31900422
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
多配体协同作用对铬在动物皮内的渗透-结合性能和交联强度的调控机制及应用
  • 批准号:
    21908149
  • 批准年份:
    2019
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
  • 批准号:
    10595404
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
  • 批准号:
    10636329
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies
基于同种异体 BAFF 配体的 CAR T 细胞作为 B 细胞恶性肿瘤的新疗法
  • 批准号:
    10698759
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
DRUG DISCOVERY BY DIRECTED EVOLUTION IN MAMMALIAN CELLS
通过哺乳动物细胞定向进化发现药物
  • 批准号:
    10644749
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
  • 批准号:
    10644874
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了